Drug intelligence / Profile preview

polaprezinc

Development stage
Phase 4
Lead developer
Hamari Chemicals
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Peptides
Administration
Oral
01

Overview

Polaprezinc is an orally bioavailable chelate composed of zinc and L-carnosine, primarily used as a gastric mucosal protective agent. It is approved in Japan for the treatment and prevention of gastric ulcers and gastritis. Polaprezinc exerts cytoprotective, antioxidant, anti-ulcer, and anti-inflammatory effects by increasing the expression of antioxidant enzymes (such as SOD-1/2, HO-1), inhibiting pro-inflammatory cytokines (including TNF-alpha and IL-6), upregulating growth factors (PDGF-B, VEGF, NGF), and stimulating heat shock proteins (HSP90/70/60/47/27/10). Its mechanism includes scavenging reactive oxygen species in the gastric mucosa to protect cells from oxidative damage while promoting tissue repair. Polaprezinc also inhibits nuclear factor-kappaB activity to reduce inflammation and has demonstrated efficacy in improving healing rates for peptic ulcers as well as potential benefits for oral mucositis associated with cancer therapy[1][2][3][4][5][6].

Brand names
PromacPepZin GI
Other names
zinc L-carnosinezinc-carnosine complexZnC
02

Targets

PDGFRB (Platelet-derived growth factor receptor beta)HSP90AB1 (Heat shock protein HSP 90-beta)VEGFR-1 (Vascular endothelial growth factor receptor 1)NGF (Nerve growth factor)HSP90AA1 (Heat shock protein HSP90-alpha)IL-6 (Interleukin 6)TNFA (Tumor necrosis factor alpha (soluble))IL3 (IL-3)

Beyond the preview

Go deeper on polaprezinc.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polaprezinc.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call